Results 211 to 220 of about 218,068 (352)

Comparison of central nervous system prophylaxis with cranial radiation and intrathecal methotrexate versus intrathecal methotrexate alone in acute lymphoblastic leukemia [PDF]

, 1983
FS Muriel, E Svarch, S Pavlovsky, M Eppinger-Helft, J Braier, Beatriz Iade Vergara, G Garay, R Kvicala, JM Divito, R Failace, Eduardo Dibar, E Jimenez   +11 more
openalex   +1 more source

Improved outcomes in elderly patients with acute lymphoblastic leukaemia using a paediatric‐based protocol—A prospective study

British Journal of Haematology, EarlyView.
In this population‐based study the relapse rates were remarkably low in patients reaching day 79 with active treatment, challenging the widely accepted belief that ALL is difficult to cure in the elderly. Summary Population data have shown that the prognosis for elderly patients with acute lymphoblastic leukaemia (ALL) is poor, even in the modern era ...
P. Quist‐Paulsen, L. Horvei, J. Dalgaard, M. Moksnes, A. L. Eilertsen, M. Paulson, N. A. Azrakhsh, W. Majeed, H. S. Wik   +8 more
wiley   +1 more source

Management of relapsed acute lymphoblastic leukemia in a patient with down syndrome: A case report. [PDF]

Leuk Res Rep
Almatar E, Alsharidah S, Hashem OA.
europepmc   +1 more source

Marrow transplantation for patients with acute lymphoblastic leukemia: a long-term follow-up

, 1983
Thomas Ed, JE Sanders, Nancy Flournoy, F L Johnson, CD Buckner, Clift Ra, A Fefer, BW Goodell, Rainer Storb, PL Weiden   +9 more
openalex   +1 more source

Biochemical and Immunological Properties of Human Terminal Deoxynucleotidyl Transferase Purified from Blasts of Acute Lymphoblastic and Chronic Myelogenous Leukemia [PDF]

, 1981
Martin R. Deibel, Mary Sue Colemán, Karen Acree, John J. Hutton   +3 more
openalex   +1 more source

Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party

British Journal of Haematology, EarlyView.
We retrospectively evaluated outcomes after a second haematopoietic stem cell transplantation (HSCT) performed between 2000 and 2022 for relapsed acute myeloid leukaemia in 345 children. We found that leukaemia‐free survival, overall survival, graft‐versus‐host disease (GVHD)/relapse‐free survival (GRFS) and relapse incidence improved over time, while ...
Nimrod Buchbinder, Victor Michel, Arnaud Dalissier, Katharina Kleinschmidt, Franco Locatelli, Alexei Maschan, Robert Wynn, Franca Fagioli, Marco Zecca, Charlotte Jubert, Birgitta Versluys, Petr Sedlacek, Ludmila Zubarovskaya, Marta Gonzalez Vicent, Alessandra Biffi, Gérard Michel, Oana Mirci‐Danicar, Wolfgang Holter, Marc Ansari, Jacques‐Emmanuel Galimard, Pascale Schneider, Mouad Abouqateb, Krzysztof Kałwak   +22 more
wiley   +1 more source

Oncologists' preferences for frontline TKI treatment of Ph+ acute lymphoblastic leukemia: a discrete choice experiment. [PDF]

Future Oncol
Ashaye A, Ramachandran N, Quaife M, Wu Y, Gutiérrez-Vargas ÁA, Jiongco A, Kota V, Savani B, Thomas C.   +8 more
europepmc   +1 more source

Heterogeneity of cultured leukemic lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients. [PDF]

, 1987
Fatih M. Uckun, John H. Kersey, K Gajl-Peczalska, Nyla A. Heerema, Arthur J. Provisor, D. Haag, Gerald Gilchrist, C. W. Song, D Arthur, James S. Roloff   +9 more
openalex   +1 more source

Hypothermia in Acute Lymphoblastic Leukemia

Annals of Saudi Medicine, 1994
Fahad Z. Fiar, Hugh M. Clink, Bent Stigsby   +2 more
openaire   +3 more sources

Impact of methotrexate‐dosing regimens for GVHD prophylaxis on clinical outcomes of HLA‐matched allogeneic HSCT

British Journal of Haematology, EarlyView.
Summary Severe graft‐versus‐host disease (GVHD) remains a major complication of allogeneic haematopoietic stem cell transplantation (allo‐HSCT), necessitating optimal immunosuppressive strategies. This retrospective study used data from the Japanese Transplant Registry Unified Management Program to compare three methotrexate (MTX)‐dosing regimens for ...
Tomotaka Suzuki, Tomoyasu Jo, Kota Yoshifuji, Tadakazu Kondo, Noriko Doki, Yoshinobu Kanda, Tetsuya Nishida, Yasushi Onishi, Noboru Asada, Takahiro Fukuda, Masashi Sawa, Yuta Hasegawa, Kentaro Serizawa, Shuichi Ota, Masatsugu Tanaka, Makoto Yoshimitsu, Yoshiko Atsuta, Junya Kanda   +17 more
wiley   +1 more source